Literature DB >> 15954990

Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.

M J Kjolby1, E Kompanowska-Jezierska, S Wamberg, P Bie.   

Abstract

AIMS: The operating range of the renin-angiotensin-aldosterone system is ill-defined. This study quantifies renin-angiotensin-aldosterone system activity as a function of sodium intake.
METHODS: Renin-angiotensin-aldosterone system variables were measured daily after a sudden reduction in sodium intake (3.0-0.5 mmol kg(-1) day(-1)) or at steady states generated by eight levels of sodium intake (0.5-8.0 mmol kg(-1) day(-1)). Potassium intake was 2.79 +/- 0.03 mmol kg(-1) day(-1). Arterial blood pressure was measured invasively. Hormone concentrations were determined by radioimmunoassays. Glomerular filtration rate and plasma volume were determined by standard methods.
RESULTS: Sudden sodium intake reduction doubled plasma renin activity and angiotensin II, and tripled aldosterone on day 1 with only small non-significant additional changes on the following days. Different levels of sodium intake did not affect arterial blood pressure, heart rate, and plasma concentrations of sodium, angiotensinogen, atrial natriuretic peptide, vasopressin, glomerular filtration rate and diuresis. With increasing sodium intake, plasma volume increased by 0.47 +/- 0.04 mL (kg body mass)(-1) (unit increase in Na intake)(-1) (P < 0.01), and plasma potassium decreased with the slope -0.038 mm [(mmol Na+ intake) (kg body mass)(-1) day(-1)](-1) (P = 0.001) while plasma renin-activity, angiotensin II, and aldosterone decreased systematically as expected.
CONCLUSIONS: A step reduction in sodium intake alters renin-angiotensin-aldosterone system activity on day 1 with little further change the subsequent 4 days. Week-long increases in sodium intake decreases renin-angiotensin-aldosterone system activity, increases plasma volume, and decreases plasma potassium. Isolated decreases in sodium intake increase aldosterone secretion via volume-mediated action on the renin-angiotensin system and via increases in plasma potassium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954990     DOI: 10.1111/j.1365-201X.2005.01452.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  6 in total

1.  Reply from V. A. Averina, H. G. Othmer, G. D. Fink and J. W. Osborn.

Authors:  Viktoria A Averina; Hans G Othmer; Gregory D Fink; John W Osborn
Journal:  J Physiol       Date:  2013-06-01       Impact factor: 5.182

2.  Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.

Authors:  Jonathan P Mochel; Martin Fink; Mathieu Peyrou; Antoine Soubret; Jérôme M Giraudel; Meindert Danhof
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

3.  Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.

Authors:  Mads Damkjaer; Gorm Nielsen; Silke Bodendiek; Mette Staehr; Jan-Bert Gramsbergen; Cor de Wit; Boye L Jensen; Ulf Simonsen; Peter Bie; Heike Wulff; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Enhanced angiotensin-converting enzyme activity and systemic reactivity to angiotensin II in normotensive rats exposed to a high-sodium diet.

Authors:  Sandra Crestani; Arquimedes Gasparotto Júnior; Maria C A Marques; Jennifer C Sullivan; R Clinton Webb; J Eduardo da Silva-Santos
Journal:  Vascul Pharmacol       Date:  2013-12-07       Impact factor: 5.773

5.  CD8+ T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension.

Authors:  Yunmeng Liu; Tonya M Rafferty; Sung W Rhee; Jessica S Webber; Li Song; Benjamin Ko; Robert S Hoover; Beixiang He; Shengyu Mu
Journal:  Nat Commun       Date:  2017-01-09       Impact factor: 14.919

6.  Characterization of the intrarenal renin-angiotensin system in cats with naturally occurring chronic kidney disease.

Authors:  Bianca N Lourenço; Amanda E Coleman; Roy D Berghaus; Jaime L Tarigo; Chad W Schmiedt; Scott A Brown
Journal:  J Vet Intern Med       Date:  2022-01-19       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.